This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will support research to investigate the exposure and health effects of using new and emerging electronic cigarette (e-cigarette) devices among young adults. The $549,555.45 award to the University of Pennsylvania will fund a cross-sectional study to: 1) evaluate the relationship between...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) aims to develop and evaluate improved labeling for nicotine content and emissions in electronic nicotine delivery systems (ENDS) products. The $784,418 project, awarded to Yale University and running from July 2024 to June 2027, will refine a new nicotine concentration label to replace current...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $1,615,000 to The Regents of the University of California, San Francisco (UCSF) to investigate the cardiovascular effects of dual use of cigarettes and electronic cigarettes (e-cigarettes). The research project aims to: 1) Understand the cardiovascular health effects of dual use of a...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,973,823 to The Medical University of South Carolina (MUSC) to evaluate a tobacco harm reduction strategy among clients enrolled in substance use disorder (SUD) treatment. The study will conduct a hybrid type 1 effectiveness-implementation randomized controlled trial to assess the impact of switching to electronic nicotine delivery...
This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the relative risks of tobacco products. The project aims to generate effective messaging on the continuum of tobacco product risks, assess their impact on message response, receptivity, and behavioral precursors,...
The National Institutes of Health (NIH), through the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), awarded a $669,321 project grant to the Regents of the University of California at Riverside (UC Riverside). The grant supports a 1-year study to characterize new and emerging ingredients, acids, toxicants, and indicators of non-tobacco nicotine in electronic cigarette (e-cigarette) products. The research will involve: Analyzing 600 commercial...
This Project Grant award of $1,951,307 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Medical University of South Carolina (MUSC). The funding will support a longitudinal cohort study investigating the use patterns and trajectories of dual users of combustible and electronic cigarettes, to better understand how these patterns relate to smoking cessation. The study, led by researchers at MUSC and the University...
This federal Project Grant award of $623,177 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to study the effects of maternal exposure to electronic nicotine delivery system (ENDS) aerosols during pregnancy on addiction-related behaviors and reinforcement-related neurocircuitry in offspring. The primary goal is to use animal models to better understand how maternal ENDS use can adversely impact impulsivity, nicotine addiction...
This federal Project Grant award, funded by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), aims to identify and develop educational messages that can effectively communicate the relative risks of e-cigarettes compared to combustible cigarettes. The $171,742 award to Rutgers, The State University of New Jersey will: Identify belief patterns about the harms of cigarettes versus...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $622,957 to Duke University to conduct research on the chemical composition and behavioral effects of novel tobacco products. The key objectives are to: 1) Analyze the chemical composition of oral nicotine pouches and "non-menthol" cigarettes for flavors, sweeteners, and...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $602,496 to the University of Oklahoma Health Sciences Center to conduct a longitudinal study examining the impact of electronic nicotine delivery system (ENDS) product characteristics on use behaviors and abuse liability among young adult ENDS users. The study will utilize a combination of traditional surveys and ecological momentary assessment (EMA) methods to capture real-time, real-world data on ENDS use patterns, product characteristics, and dependence. The primary objectives are to: 1) assess concordance between survey and EMA measures of ENDS use, product characteristics, and abuse liability; 2) examine the effect of ENDS product characteristics on tobacco use behaviors; and 3) investigate how changes in ENDS product characteristics impact dependence and use behaviors among young adults. The research aims to provide the FDA with more accurate, granular data to inform their regulatory authority over ENDS products.